{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "LOINC|ACTIVE|CHEM|CSF" in comments (approximate match)
Status:
Investigational
Source:
NCT00484757: Not Applicable Interventional Unknown status Narcolepsy
(2007)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04426201: Phase 2 Interventional Terminated COVID-19
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01309425: Phase 1 Interventional Completed Healthy Volunteer
(2011)
Source URL:
Class:
PROTEIN
Status:
Designated
Source:
EU-Orphan Drug:EU/3/03/138
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT01715493: Phase 4 Interventional Completed Chronic Obstructive Pulmonary Disease
(2012)
Source URL:
First approved in 2012
Source:
21 CFR 346
Source URL:
Class:
PROTEIN
